Literature DB >> 25550114

Therapeutic vaccination in chronic hepatitis B--approaches, problems, and new perspectives. Preface.

Wolfram Gerlich1, Hans-Wilhelm Doerr.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 25550114     DOI： 10.1007/s00430-014-0368-8

Source DB:  PubMed          Journal:  Med Microbiol Immunol        ISSN： 0300-8584            Impact factor:   3.402


× No keyword cloud information.
  8 in total

1.  [Prophylaxis, diagnosis and therapy of hepatitis B virus infection - the German guideline].

Authors:  M Cornberg; U Protzer; J Petersen; H Wedemeyer; T Berg; W Jilg; A Erhardt; S Wirth; C Sarrazin; M M Dollinger; P Schirmacher; K Dathe; I B Kopp; S Zeuzem; W H Gerlich; M P Manns
Journal:  Z Gastroenterol       Date:  2011-07-11       Impact factor: 2.000

Review 2.  Vaccination against infectious diseases: what is promising?

Authors:  Hans Wilhelm Doerr; Annemarie Berger
Journal:  Med Microbiol Immunol       Date:  2014-07-27       Impact factor: 3.402

3.  The state of hepatitis B and C in Europe: report from the hepatitis B and C summit conference*.

Authors:  A Hatzakis; S Wait; J Bruix; M Buti; M Carballo; M Cavaleri; M Colombo; E Delarocque-Astagneau; G Dusheiko; G Esmat; R Esteban; D Goldberg; C Gore; A S F Lok; M Manns; P Marcellin; G Papatheodoridis; A Peterle; D Prati; N Piorkowsky; M Rizzetto; F Roudot-Thoraval; V Soriano; H C Thomas; M Thursz; D Valla; P van Damme; I K Veldhuijzen; H Wedemeyer; L Wiessing; A R Zanetti; H L A Janssen
Journal:  J Viral Hepat       Date:  2011-09       Impact factor: 3.728

4.  Genomic analysis of the host response to hepatitis B virus infection.

Authors:  Stefan Wieland; Robert Thimme; Robert H Purcell; Francis V Chisari
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-20       Impact factor: 11.205

5.  Enhancing virus-specific immunity in vivo by combining therapeutic vaccination and PD-L1 blockade in chronic hepadnaviral infection.

Authors:  Jia Liu; Ejuan Zhang; Zhiyong Ma; Weimin Wu; Anna Kosinska; Xiaoyong Zhang; Inga Möller; Pia Seiz; Dieter Glebe; Baoju Wang; Dongliang Yang; Mengji Lu; Michael Roggendorf
Journal:  PLoS Pathog       Date:  2014-01-02       Impact factor: 6.823

Review 6.  Human immunodeficiency virus: 25 years of diagnostic and therapeutic strategies and their impact on hepatitis B and C virus.

Authors:  Martin Stürmer; Hans Wilhelm Doerr; Lutz Gürtler
Journal:  Med Microbiol Immunol       Date:  2009-06-04       Impact factor: 3.402

7.  Combination of DNA prime--adenovirus boost immunization with entecavir elicits sustained control of chronic hepatitis B in the woodchuck model.

Authors:  Anna D Kosinska; Ejuan Zhang; Lena Johrden; Jia Liu; Pia L Seiz; Xiaoyong Zhang; Zhiyong Ma; Thekla Kemper; Melanie Fiedler; Dieter Glebe; Oliver Wildner; Ulf Dittmer; Mengji Lu; Michael Roggendorf
Journal:  PLoS Pathog       Date:  2013-06-13       Impact factor: 6.823

Review 8.  Medical virology of hepatitis B: how it began and where we are now.

Authors:  Wolfram H Gerlich
Journal:  Virol J       Date:  2013-07-20       Impact factor: 4.099
  8 in total
  1 in total

1.  Fighting cytomegalovirus-caused diseases: the immunologic approach.

Authors:  H W Doerr
Journal:  Med Microbiol Immunol       Date:  2016-12       Impact factor: 3.402
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.